Location: New York, NY
CIK: 0001493215 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 16, 2021
Total Value: $5.96B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc | 17,060,211 | $936M | 15.7% | $16.66 | +118.8% | COM | 77313F106 |
| IMVT | Immunovant Inc | 7,592,253 | $351M | 5.9% | $17.76 | +160.4% | COM | 45258J102 |
| PTCT | PTC Therapeutics Inc | 4,221,836 | $258M | 4.3% | $28.56 | +106.4% | COM | 69366J200 |
| — | Mirati Therapeutics Inc | 1,054,364 | $232M | 3.9% | $81.49 | — | COM | 60468T105 |
| STOK | Stoke Therapeutics Inc | 3,544,248 | $219M | 3.7% | $26.76 | +71.3% | COM | 86150R107 |
| ALNY | Alnylam Pharmaceuticals Inc | 1,681,645 | $219M | 3.7% | $80.21 | +66.5% | COM | 02043Q107 |
| NTRA | Natera Inc | 1,712,234 | $170M | 2.9% | $36.53 | +128.7% | COM | 632307104 |
| — | Dicerna Pharmaceuticals Inc | 7,253,857 | $160M | 2.7% | $12.64 | — | COM | 253031108 |
| ARVN | Arvinas Inc | 1,790,996 | $152M | 2.6% | $34.48 | 0.0% | COM | 04335A105 |
| VCEL | Vericel Corp | 4,517,570 | $140M | 2.3% | $12.98 | +83.4% | COM | 92346J108 |
| AXSM | Axsome Therapeutics Inc | 1,672,416 | $136M | 2.3% | $40.14 | +86.3% | COM | 05464T104 |
| ILMN | Illumina Inc | 361,778 | $134M | 2.2% | $331.25 | -3.8% | COM | 452327109 |
| — | Cerner Corp | 1,701,680 | $134M | 2.2% | $70.82 | — | COM | 156782104 |
| MASI | Masimo Corp | 469,416 | $126M | 2.1% | $117.24 | +112.7% | COM | 574795100 |
| GMED | Globus Med Inc | 1,640,859 | $107M | 1.8% | $57.49 | 0.0% | CL A | 379577208 |
| RNAM | Avidity Biosciences Inc | 3,995,000 | $102M | 1.7% | $28.83 | +1.1% | COM | 05370A108 |
| TARS | Tarsus Pharmaceuticals Inc. | 2,463,601 | $98.99M | 1.7% | $28.48 | 0.0% | COM | 87650L103 |
| — | Axonics Modulation Technolog | 1,883,864 | $94.04M | 1.6% | $20.01 | — | COM | 05465P101 |
| DMTKQ | DermTech Inc | 2,887,215 | $93.66M | 1.6% | $6.46 | — | COM | 24984K105 |
| TXG | 10x Genomics Inc | 660,933 | $93.59M | 1.6% | $78.78 | +84.2% | CL A COM | 88025U109 |
| — | Athira Pharma Inc | 2,685,779 | $88.9M | 1.5% | $17.00 | — | COM | 04746L104 |
| ESTA | Establishment Labs Hldgs Inc | 2,319,138 | $87.29M | 1.5% | $24.65 | +6.9% | COM | G31249108 |
| — | Frequency Therapeutics Inc | 2,461,486 | $86.79M | 1.5% | $17.59 | — | COM | 35803L108 |
| — | Adverum Biotechnologies Inc | 7,227,364 | $78.34M | 1.3% | $4.47 | — | COM | 00773U108 |
| GH | Guardant Health Inc | 581,970 | $75M | 1.3% | $96.04 | +19.8% | COM | 40131M109 |
| LUNG | Pulmonx Corp | 1,129,600 | $74.84M | 1.3% | $48.97 | 0.0% | COM | 745848101 |
| PTGX | Protagonist Therapeutics Inc | 3,650,069 | $73.58M | 1.2% | $11.65 | +84.8% | COM | 74366E102 |
| CCCC | C4 Therapeutics Inc | 2,149,228 | $68.68M | 1.2% | $29.00 | 0.0% | COM STK | 12529R107 |
| TNDM | Tandem Diabetes Care Inc | 660,982 | $63.24M | 1.1% | $75.24 | +37.0% | COM NEW | 875372203 |
| CLDX | Celldex Therapeutics Inc New | 3,422,855 | $59.97M | 1.0% | $6.72 | +167.9% | COM NEW | 15117B202 |
| KURA | Kura Oncology Inc | 1,701,781 | $55.58M | 0.9% | $35.14 | 0.0% | COM | 50127T109 |
| — | Translate Bio Inc | 2,978,427 | $54.89M | 0.9% | $10.74 | — | COM | 89374L104 |
| — | NanoString Technologies Inc | 804,029 | $53.77M | 0.9% | $26.11 | — | COM | 63009R109 |
| CSTL | Castle Biosciences Inc | 799,009 | $53.65M | 0.9% | $26.48 | +104.7% | COM | 14843C105 |
| RLMD | Relmada Therapeutics Inc | 1,512,673 | $48.51M | 0.8% | $35.61 | -3.5% | COM | 75955J402 |
| — | IVERIC bio Inc | 6,722,624 | $46.45M | 0.8% | $5.11 | — | COM | 46583P102 |
| — | Five Prime Therapeutics Inc | 2,515,788 | $42.79M | 0.7% | $17.01 | — | COM | 33830X104 |
| CYTK | Cytokinetics Inc | 2,000,000 | $41.31M | 0.7% | $23.39 | -21.9% | COM NEW | 23282W605 |
| — | Agenus Inc | 12,864,677 | $40.91M | 0.7% | $4.63 | — | COM NEW | 00847G705 |
| — | Oyster Pt Pharma Inc | 1,925,594 | $36.24M | 0.6% | $31.99 | — | COM | 69242L106 |
| — | Avadel Pharmaceuticals plc | 5,387,513 | $35.99M | 0.6% | $7.66 | — | SPONSORED ADR | 05337M104 |
| — | Iteos Therapeutics Inc | 1,074,166 | $35.98M | 0.6% | $24.80 | — | COM | 46565G104 |
| — | Outset Med Inc | 585,074 | $33.26M | 0.6% | $52.11 | — | COM | 690145107 |
| — | Trillium Therapeutics Inc | 2,165,197 | $31.85M | 0.5% | $14.21 | — | COM NEW | 89620X506 |
| PMVP | Pmv Pharmaceuticals Inc | 500,882 | $30.81M | 0.5% | $36.80 | +6.6% | COM | 69353Y103 |
| — | Curis Inc | 3,727,360 | $30.53M | 0.5% | $8.19 | — | COM NEW | 231269200 |
| — | Berkeley Lts Inc | 324,734 | $29.03M | 0.5% | $77.34 | — | COM | 084310101 |
| MIST | Milestone Pharmaceuticals In | 4,315,102 | $28.91M | 0.5% | $20.06 | -66.6% | COM | 59935V107 |
| MGNX | MacroGenics Inc | 1,256,409 | $28.72M | 0.5% | $17.37 | +32.5% | COM | 556099109 |
| IDYA | Ideaya Biosciences Inc | 1,846,843 | $25.86M | 0.4% | $13.55 | 0.0% | COM | 45166A102 |
| MDXG | MiMedx Group Inc | 2,700,320 | $24.52M | 0.4% | $5.08 | +35.3% | COM | 602496101 |
| APYX | Apyx Medical Corporation | 3,391,279 | $24.42M | 0.4% | $7.55 | -12.2% | COM | 03837C106 |
| FULC | Fulcrum Therapeutics Inc | 2,071,409 | $24.26M | 0.4% | $11.71 | -3.5% | COM | 359616109 |
| JNJ | Johnson & Johnson | 149,761 | $23.57M | 0.4% | $116.08 | +9.9% | COM | 478160104 |
| ABUS | Arbutus Biopharma Corp | 5,978,355 | $21.22M | 0.4% | $3.30 | +6.0% | COM | 03879J100 |
| PRQR | ProQR Thrapeutics N V | 5,009,768 | $21.04M | 0.4% | $12.63 | -66.6% | SHS EURO | N71542109 |
| TELA | Tela Bio Inc | 1,383,816 | $20.81M | 0.3% | $12.40 | +30.9% | COM | 872381108 |
| PEN | Penumbra Inc | 118,273 | $20.7M | 0.3% | $219.06 | 0.0% | COM | 70975L107 |
| — | Odonate Therapeutics Inc | 1,000,139 | $19.2M | 0.3% | $20.24 | — | COM | 676079106 |
| XGN | Exagen Inc | 1,250,131 | $16.5M | 0.3% | $17.92 | -21.2% | COM | 30068X103 |
| — | Bellus Health Inc New | 5,189,862 | $15.78M | 0.3% | $6.44 | — | COM NEW | 07987C204 |
| IMUX | Immunic Inc | 920,814 | $14.08M | 0.2% | $16.38 | +9.6% | COM | 4525EP101 |
| AFIB | Acutus Med Inc | 451,834 | $13.02M | 0.2% | $30.36 | -10.8% | COM | 005111109 |
| RGNX | Regenxbio Inc | 282,260 | $12.8M | 0.2% | $25.74 | +35.7% | COM | 75901B107 |
| — | GenMark Diagnostics Inc | 762,994 | $11.14M | 0.2% | $14.71 | — | COM | 372309104 |
| — | Clearside Biomedical Inc | 3,958,130 | $10.85M | 0.2% | $0.67 | — | COM | 185063104 |
| — | Aptevo Therapeutics Inc | 288,236 | $10.56M | 0.2% | $36.65 | — | COM NEW | 03835L207 |
| — | Vincera Pharma Inc | 500,000 | $10.46M | 0.2% | $20.91 | — | COM | 92731L106 |
| CTMX | Cytomx Therapeutics Inc | 1,527,352 | $10M | 0.2% | $12.72 | -43.9% | COM | 23284F105 |
| ARGX | argenx SE | 31,752 | $9.338M | 0.2% | $37.72 | — | SPONSORED ADR | 04016X101 |
| — | La Jolla Pharmaceutical Co | 2,397,378 | $9.302M | 0.2% | $10.40 | — | COM PAR $.0001 2 | 503459604 |
| MLTX | Helix Acquisition Corp | 750,000 | $8.528M | 0.1% | $11.37 | — | COM CL A | G4444C102 |
| BWAY | Brainsway Ltd | 1,103,474 | $8.32M | 0.1% | $9.77 | — | SPONSORED ADS | 10501L106 |
| — | Cerevel Therapeutics Hldng I | 500,000 | $8.29M | 0.1% | $16.58 | — | COM | 15678U128 |
| SRRK | Scholar Rock Hldg Corp | 166,183 | $8.065M | 0.1% | $36.31 | 0.0% | COM | 80706P103 |
| — | Lifesci Acquisition Ii Corp | 650,000 | $6.936M | 0.1% | $10.67 | — | COM | 53229E103 |
| — | BCTG Acquisition Corp | 600,000 | $6.864M | 0.1% | $10.36 | — | COM | 05492W103 |
| — | Bcls Acquisition Corp | 612,500 | $6.823M | 0.1% | $11.14 | — | COM CL A | G0904B105 |
| — | Therapeutics Acquisition Cor | 490,000 | $6.821M | 0.1% | $14.38 | — | COM CL A | 88339T103 |
| INMD | Inmode Ltd | 124,999 | $5.935M | 0.1% | $11.40 | +85.3% | SHS | M5425M103 |
| — | Arya Sciences Acquisition Co | 500,000 | $5.425M | 0.1% | $10.82 | — | COM CL A | G3166W106 |
| PSNL | Personalis Inc | 127,501 | $4.668M | 0.1% | $27.18 | +11.2% | COM | 71535D106 |
| — | Itamar Med Ltd | 228,609 | $4.54M | 0.1% | $11.78 | — | SPONSORED ADS | 465437101 |
| — | 5 01 Acquisition Corp | 392,000 | $3.987M | 0.1% | $10.17 | — | COM CL A | 33836P105 |
| — | Panacea Acquisition Corp | 300,000 | $3.828M | 0.1% | $12.00 | — | UNIT 99/99/9999 | 698102209 |
| — | Biomx Inc | 600,000 | $3.828M | 0.1% | $9.69 | — | COM | 09090D103 |
| IMTX | Immatics N.V | 350,000 | $3.777M | 0.1% | $10.53 | +0.1% | SHS | N44445109 |
| — | Chardan Healthcr Acqstn 2 Co | 350,000 | $3.707M | 0.1% | $10.50 | — | UNIT 99/99/9999 | 15957T206 |
| TWST | Twist Bioscience Corp | 18,473 | $2.61M | 0.0% | $28.42 | +290.4% | COM | 90184D100 |
| — | Biodesix Inc | 125,000 | $2.52M | 0.0% | $20.16 | — | COM | 09075X108 |
| PROF | Profound Med Corp | 122,098 | $2.51M | 0.0% | $13.80 | +33.3% | COM NEW | 74319B502 |
| MASS | 908 Devices Inc | 40,000 | $2.278M | 0.0% | $58.41 | 0.0% | COM | 65443P102 |
| MRVI | Maravai Lifesciences Hldgs I | 70,000 | $1.964M | 0.0% | $27.85 | 0.0% | COM CL A | 56600D107 |
| OSUR | OraSure Technologies Inc | 184,000 | $1.948M | 0.0% | $13.16 | -0.3% | COM | 68554V108 |
| ELUT | Aziyo Biologics Inc | 125,000 | $1.704M | 0.0% | $12.50 | 0.0% | COM CL A | 05479K106 |
| — | Vincera Pharma Inc | 500,000 | $1.65M | 0.0% | $3.30 | — | *W EXP 12/24/202 | 92731L114 |
| — | Cerevel Therapeutics Hldng I | 166,666 | $942K | 0.0% | $5.65 | — | *W EXP 06/09/202 | 15678U102 |
| — | Burning Rock Biotech Ltd | 30,000 | $693K | 0.0% | $27.00 | — | SPONSORED ADS | 12233L107 |
| — | Progenity Inc | 100,000 | $531K | 0.0% | $9.00 | — | COM | 74319F107 |
| — | BiomX Inc | 600,000 | $480K | 0.0% | $0.48 | — | *W EXP 10/16/202 | 09090D111 |
| BCAB | Bioatla Inc | 10,000 | $340K | 0.0% | $33.43 | 0.0% | COM | 09077B104 |
| SEER | Seer Inc | 4,000 | $225K | 0.0% | $63.62 | 0.0% | COM CL A | 81578P106 |